Heron Bay Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Heron Bay Capital Management's BIIB Position: Q1 2022 in Review
Heron Bay Capital Management sold out of Biogen (BIIB) in Q1 2022, closing a stake of 3,177 shares — an estimated $762K sold.
Heron Bay Capital Management first reported a position in BIIB in Q4 2020 and held it in 5 quarters. The position peaked at $2.03M in Q1 2021. 952 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.
- Heron Bay Capital Management reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
- Heron Bay Capital Management sold 3,177 Biogen shares in Q1 2022, an estimated $762K.
- Heron Bay Capital Management first reported a position in Biogen in Q4 2020 and held it in 5 quarters.
- Heron Bay Capital Management's Biogen position peaked at $2.03M in Q1 2021.
- 952 funds tracked by Wall St. Rank held Biogen as of Q1 2022.
Based on Heron Bay Capital Management's 13F filing for Q1 2022, filed 16 May 2022.